Illustration(s) pertain to the topic addressed in this publication, not the specific research or data presented in the publication

Management of occupational exposures to hepatitis C virus: current practice and controversies

Abstract

Unlike hepatitis B virus and human immunodeficiency virus, there currently are no immunization or chemoprophylactic interventions available to prevent infection after an occupational exposure to hepatitis C virus (HCV). A “Reality Check” session was held at the 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections to gather information on current practices related to management of occupational exposures to HCV, generate discussion on controversial issues, and identify areas for future research. Infection control professionals in attendance were knowledgeable in most issues addressed regarding the management of occupational exposures to HCV. Areas of controversy included the use of antiviral therapy early in the course of HCV infection and the appropriate administrative management of an HCV-infected healthcare worker.

Alvarado-Ramy F, Alter MJ, Bower W, Henderson DK, Sohn AH, Sinkowitz-Cochran RL, Jarvis WR

Infect Control Hosp Epidemiol 2001 Jan;22(1):53-5

PMID: 11198026

Management of occupational exposures to hepatitis C virus: current practice and controversies was last modified: January 1st, 2001 by Alvarado-Ramy F, Alter MJ, Bower W, Henderson DK, Sohn AH, Sinkowitz-Cochran RL, Jarvis WR